EYEPOINT PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.096 EUR | +8.12% |
|
+8.18% | -61.81% |
| 06-26 | EyePoint Pharmaceuticals, Inc. Highlights Duravuyu Clinical and Regulatory Progress and Pipeline Innovation At R&D Day 2024 | CI |
| 06-26 | Transcript : EyePoint Pharmaceuticals, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 815B | ||||||
| 352B | - | - | - | - | ||
| 314B | ||||||
| 303B | ||||||
| 242B |
